A prognostic model for the prediction of survival in cystic fibrosis

Thorax

Volumn 52, Issue 4, 1997, Pages 313-317

  Hayllar, Karen M ^a   Williams, Simon G J ^b   Wise, Amelia E ^c   Pouria, Shideh ^a   Lombard, Martin ^a   Hodson, Margaret E ^c   Westaby, David ^b  

^a KING S COLLEGE HOSPITAL   (United Kingdom)

^b CHARING CROSS HOSPITAL   (United Kingdom)

^c ROYAL BROMPTON HOSPITAL   (United Kingdom)

Author keywords

Cystic fibrosis; Prognostic model

Indexed keywords

ADULT; ARTICLE; CHILD; COHORT ANALYSIS; CYSTIC FIBROSIS; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; LIVER DISEASE; LUNG TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MODEL; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL; VITAL CAPACITY;

EID: 0030959076     PISSN: 00406376     EISSN: None     Source Type: Journal    
DOI: 10.1136/thx.52.4.313     Document Type: Article

References (37)

1. Wood RE, Boat TF, Doershuk CF. Cystic fibrosis. Am Rev Respir Dis 1976;113:833-78.
2. British Paediatric Association Working Party on Cystic Fibrosis. Cystic fibrosis in the United Kingdom 1977-1985, an improving picture. BMJ 1988;297:1599-602.
3. MacLusky I, Levison H. Cystic fibrosis. In: Chernick V, ed. Disorders of the respiratory tract in children. Philadelphia: WB Saunders, 1990:692-729.
4. Madden BP, Hodson ME, Tsang V, Radley-Smith R, Khaghani A, Yacoub MY. Intermediate-term results of heart-lung transplantation for cystic fibrosis. Lancet 1992;i: 1583-7.
5. Scott J, Higenbottam T, Hutter J, Hodson M, Stewart S, Penketh A, et al. Heart-lung transplantation for cystic fibrosis. Lancet 1988;ii:192-4.
6. Whitehead B, Helms P, Goodwin M, Martin I, Scott JP, Smyth RL, et al. Heart-lung transplantation for cystic fibrosis. 2. Outcome. Arch Dis Child 1991;66:1022-6.
7. Whitehead B, Helms P, Goodwin M, Martin I, Lask B, Serrano E, et al. Heart-lung transplantation for cystic fibrosis. 1. Assessment. Arch Dis Child 1991;66:1018-21.
8. Kerem E, Reisman J, Corey M, Canny GJ, Levison H. Prediction of mortality in patients with cystic fibrosis. N Engl J Med 1992;326:1187-91.
9. Bates DV, Macklem PT, Christie RV. Respiratory function in disease. Philadelphia: WB Saunders, 1971:93-4.
10. Society of Actuaries (Chicago). Build and blood pressure study. New York: Peter F Mallon Inc, 1959:16-23.
11. Christensen E, Schlichting P, Andersen PK, Fauerholdt L, Schou G, Pedersen BV, et al. Updating prognosis and therapeutic effect evaluation in cirrhosis with Cox's multiple regression model for time-dependent variables. Scand J Gastroenterol 1986;21:163-74.
12. British Paediatric Association Working Party on Cystic Fibrosis. Cystic fibrosis in the United Kingdom 1968 88: incidence, population and survival. J Paediatr Peri Epidemiol 1993;7:157-66.
13. Corey M, McLaughlin FJ, Williams M, Levison H. A comparison of survival, growth, and pulmonary function in patients with cystic fibrosis in Boston and Toronto. J Clin Epidemiol 1988;41:583-91.
14. Niellsen OH, Schiotz PO. Evaluation of centralised treatment 1945-1981. Acta Paediatr Scand 1982;Suppl 301: 107-19.
15. Henry RL, Mellis CM, Petrovic L. Mucoid Pseudomonas aeruginosa is a marker of poor survival in cystic fibrosis. Pediatr Pulmonal 1992;12:158-61.
16. Nixon PA, Orenstein DM, Kelsey SF, Doershuk CF. The prognostic value of exercise testing in patients with cystic fibrosis. N Engl J Med 1992;327:1785-8.
17. Shepherd SL, Hovell MF, Slymen DJ, Harwood IR, Hofstetter CR, Granger LE, et al. Functional status as an overall measure of health in adults with cystic fibrosis: further validation of a generic health measure. J Clin Epidemiol 1992;45:117-25.
18. Elborn JS, Shale DJ, Britton JR. Cystic fibrosis: current survival and population estimates to the year 2000. Thorax 1991;46:881-5.
19. Britton JR. Effects of social class, sex, and region of residence on age of death from cystic fibrosis. BMJ 1989;298:483-7.
20. Huang NN, Schidlow DV, Szatrowski TH, Palmer J, Laraya-Cuasay LR, Yeung W, et al. Clinical features, survival rate and prognostic factors in young adults with cystic fibrosis. Am J Med 1987;82:871-9.
21. Hudson I, Phelan PD. Are sex, age at diagnosis, or mode of presentation prognostic factors in young adults with cystic fibrosis. Pcdiatr Pulmonal 1987;3:288-97.
22. Wagener JS, Taussig LM, Burrows B, Hernried L, Boat T. Comparison of lung function and survival patterns between cystic fibrosis and emphysema or chronic bronchitis patients. In: Strurgess JM, ed. Perspectives in cystic fibrosis: proceedings of the 8th International Cystic Flbrosis Congress, Mississauga, Ontario. Mississauga: Imperial Press, 1980: 236-45.
23. Sharples L, Hathaway T, Dennis C, Caine N, Higenbottam T, Wallwork J. Prognosis of patients with cystic fibrosis awaiting heart and lung transplantation. J Heart Lung Transplant 1993;12:669-74.
24. Levy LD, Durie PR, Pencharz PB, Corey ML. Effects of long-term nutritional rehabilitation on body composition and clinical status in malnourished children and adolescents with cystic fibrosis. J Pediatr 1985;107:225-30.
25. Editorial. Survival in cystic fibrosis - how important is nutrition? Lancet 1988;ii:1060-1.
26. Elborn JS, Cordon SM, Western PJ, MacDonald IA, Shale DJ. Tumour necrosis factor-α, resting energy expenditure and cachexia in cystic fibrosis. Clin Sci 1993;85:563-8.
27. Tanner MS. Liver and biliary problems in cystic fibrosis. J R Soc Med 1992;85(Suppl 19):20-4.
28. Gaskin KJ, Waters DLM, Howman-Giles R, De Silva M, Earl JW, Martin HCO, et al. Liver disease and common-bile-duct stenosis in cystic fibrosis. N Engl J Med 1988; 318:340-6.
29. Farrant JM, Hayllar KM, Wilkinson ML, Karani J, Portmann BC, Westaby D, et al. Natural history and prognostic variables in primary sclerosing cholangitis. Gastroenterology 1991;100:1710-17.
30. Roll J, Boyer JL, Barry D, Klatskin G. The prognostic importance of clinical and histological features in asymptomatic and symptomatic primary biliary cirrhosis. N Engl J Med 1983;308:1-7.
31. Scott-Jupp R, Lama M, Tanner MS. Prevalence of liver disease in cystic fibrosis. Arch Dis Child 1991;66:698-701.
32. Sproul A, Huang NN. Growth patterns in children with cystic fibrosis. J Pediatr 1964;65:664-75.
33. Sokol RJ, Stall C. Anthropometric evaluation of children with chronic liver disease. Am J Clin Nutr 1990;52:203-8.
34. Feizi T. Immunoglobulins in chronic liver disease. Gut 1968; 9:193-8.
35. Webb LJ, Ross M, Markham RL, Webster ADW, Thomas HC, Sherlock S. Immune function in patients with extrahepatic portal venous obstruction and the effect of splenectomy. Gastroenterology 1980;79:99-103.
36. Bosch J, Arroyo V, Rodes J. Hepatic and systemic haemodynamics and the renin-angiotensin-aldosterone system in cirrhosis. In: Epstein M, ed. The kidney in liver disease. New York: Elsevier Biomedical, 1983:423-40.
37. Rodriguez-Roisin R, Agusti AGN, Roca J. Pulmonary function and liver disease. Curr Opin Gastroenterol 1988;4: 609-14.